Our insight and strategy experts work across therapeutic areas to define the evidence needs of key decision makers and develop strategic solutions that pave the way for successful market access.
Our insight and strategy experts work across therapeutic areas to define the evidence needs of key decision makers and develop strategic solutions that pave the way for successful market access.
We extract highly actionable insights from a variety of market access stakeholders to leverage unique and proven market access methodologies. Our approach ranges from traditional, structured, in-depth interviews to strategic advisory board models that combine deep critical thinking with creative and engaging meeting formats. We leverage our curated panel of market access stakeholders to select the best target for every research program. We also have global reach, with a variety of market access stakeholders and influencers in the United Kingdom, Europe, Canada, and select markets in Asia and South America.
We help our clients understand the nuanced and dynamic market access ecosystem and segment market access accounts in a way that allows for tailored, purposeful, and effective engagement. Our expertise runs the gamut from interactive “follow the dollar” assessments to robust, qualitative payer account segmentation by leveraging a variety of data sources.
IDNs require a thoughtful, well-informed approach to maximize commercial opportunity. We help our clients understand the IDN opportunity for their individual brands and create effective go-to-market strategies to help them accomplish their access and commercial goals.
We employ a series of methodologies that range from traditional war-gaming to practical simulations that emphasize both clinical and economic positioning as well as potential contracting strategies and their interplay across competitors. Our approach helps our clients better anticipate competitor behavior and gain alignment within their own organizations to quickly mitigate potential competitive threats.
We bring deep qualitative and quantitative pricing and contracting expertise to support our clients across the product life cycle. From helping to set well-informed potential price bands and “bottoms-up” forecasts for early assets to supporting late-stage assets in navigating new contracting dynamics and Medicare negotiations that are driven by the Inflation Reduction Act, we have the expertise and capabilities needed to partner with your brand for success.
Many new medical innovations are coming to market with profiles that challenge existing supply chain and reimbursement processes. Our experts can help our clients map current buying processes/practice economics and chart new approaches, which optimizes access to new therapies.
Lumanity leverages a highly differentiated combination of deep market access and health economics expertise to help clients share insights and find synergies across these important functions. Our Evidence-Generation Summits have been recognized as a cutting-edge approach to building alignment across market access and HEOR teams while adhering to firewalls and required ways of working.
We help our clients examine the landscape for key changes that have the potential to impact their portfolios and partner with them to develop assessments and plans of action accordingly.